Saelaert M, Mertes H, De Baere E, Devisch I (2018) Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 26(10):1424–1431
Article
Google Scholar
Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL et al (2019) Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med 21(5):1100–1110
Article
Google Scholar
Luijten J, van Greevenbroek MMJ, Schaper NC, Meex SJR, van der Steen C, Meijer LJ et al (2019) Incidence of cardiovascular disease in familial combined hyperlipidemia: a 15-year follow-up study. Atherosclerosis 280:1–6
Article
CAS
Google Scholar
Brouwers M, van Greevenbroek M, Stehouwer C, de Graaf J, Stalenhoef A (2012) The genetics of familial combined hyperlipidaemia. Nat Rev Endocrinol 8(6):352
Article
CAS
Google Scholar
Shah A, Wilson D (2015) Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 9(5 Suppl):S20
Article
Google Scholar
Skoumas I, Masoura C, Aznaouridis K, Metaxa V, Tsokanis A, Papadimitriou L et al (2013) Impact of cardiometabolic risk factors on major cardiovascular events in patients with familial combined hyperlipidemia. Circ J 77(1):163
Article
CAS
Google Scholar
Sentinelli F, Minicocci I, Montali A, Nanni L, Romeo S, Incani M et al (2013) Association of RXR-gamma gene variants with familial combined hyperlipidemia: genotype and haplotype analysis. J Lipids 2013:517943
Article
Google Scholar
Taghizadeh E, Esfehani R, Sahebkar A, Parizadeh S, Rostami D, Mirinezhad M et al (2019) Familial combined hyperlipidemia: an overview of the underlying molecular mechanisms and therapeutic strategies. IUBMB Life 71:1221–1229
Article
CAS
Google Scholar
Bello-Chavolla O, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo J, Tapia-González G et al (2018) Familial combined hyperlipidemia: current knowledge, perspectives, and controversies. Revista de investigacion clinica organo del Hospital de Enfermedades de la Nutricion 70(5):224
CAS
PubMed
Google Scholar
Skoumas I, Ioakeimidis N, Vlachopoulos C, Chrysohoou C, Michalakeas C, Georgakopoulos C et al (2018) Statin therapy and risk of diabetes mellitus in aging patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia: a 10-year follow-up. Angiology 69(3):242–248
Article
Google Scholar
Taghizadeh E, Mardani R, Rostami D, Taghizadeh H, Bazireh H, Hayat SMG (2019) Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: a review. J Cell Biochem 120(6):8891–8898
Article
CAS
Google Scholar
Taghizadeh E, Ghayour-Mobarhan M, Ferns G, Pasdar A (2020) A novel variant in LPL gene is associated with familial combined hyperlipidemia. BioFactors (Oxford, England) 46(1):94
Article
CAS
Google Scholar
Taghizadeh E, Mirzaei F, Jalilian N, Ghayour MM, Ferns G, Pasdar A (2020) A novel mutation in USF1 gene is associated with familial combined hyperlipidemia. IUBMB Life 72(4):616
Article
CAS
Google Scholar
Directors ABo (2015) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 17(1):68
Article
Google Scholar
Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL et al (2019) Secondary findings from clinical genomic sequencing: Prevalence, patient perspectives, family history assessment, and healthcare costs from a multi-site study. Genet Med 21(5):1100
Article
Google Scholar
Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK et al (2012) Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 91(1):97–108
Article
CAS
Google Scholar
Chen W, Li W, Ma Y, Zhang Y, Han B, Liu X et al (2018) Secondary findings in 421 whole exome-sequenced Chinese children. Hum Genomics 12(1):42
Article
CAS
Google Scholar
Liu Y-P, Ding M, Zhang X-C, Liu Y, Xuan J-F, Xing J-X et al (2019) Association between polymorphisms in the GRIN1 gene 5′ regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro. BMC Med Genet 20:26
Article
CAS
Google Scholar
Jang M, Lee S, Kim N, Ki C (2015) Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Genet Med 17(12):1007
Article
CAS
Google Scholar
Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH et al (2015) Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 25(3):305
Article
CAS
Google Scholar
Committee OG, American COMG, Genomics S, Legal IC, Bioethics CO (2013) Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3):620
Article
Google Scholar
Jalkh N, Mehawej C, Chouery E (2020) Actionable exomic secondary findings in 280 Lebanese participants. Front Genet 11:208
Article
CAS
Google Scholar
Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M et al (2012) Deleterious-and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet 91(6):1022
Article
CAS
Google Scholar
Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ et al (2013) Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am J Hum Genet 93(4):631
Article
CAS
Google Scholar
Delling FN, Vasan RS (2014) Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation 129(21):2158
Article
Google Scholar
Neubauer J, Haas C, Bartsch C, Medeiros-Domingo A, Berger W (2016) Post-mortem whole-exome sequencing (WES) with a focus on cardiac disease-associated genes in five young sudden unexplained death (SUD) cases. Int J Legal Med 130(4):1011–1021
Article
Google Scholar
Freed LA, Acierno JS Jr, Dai D, Leyne M, Marshall JE, Nesta F et al (2003) A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 72(6):1551
Article
CAS
Google Scholar
Benson DW, Sharkey A, Fatkin D, Lang P, Basson CT, McDonough B et al (1998) Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation 97(20):2043–2048
Article
CAS
Google Scholar